Santhera Enters into Equity-linked Financing to Provide up to CHF 12 million with the Option to Increase to up to CHF 24 million

8 avr. 2020

Santhera set up a flexible equity-linked financing line of up to CHF 12 million—extendable to CHF 24 million—to reinforce liquidity for its regulatory and development programs, with monthly discounted share issuances to IRIS.

Pratteln, Switzerland, April 8, 2020 – Santhera entered a CHF 12 million, 12-month equity-linked financing agreement with IRIS, giving the company full discretion to pause or terminate drawdowns and the option to double the facility to CHF 24 million over 24 months. IRIS will receive and resell newly issued shares created from authorized capital at a VWAP discount, providing Santhera with incremental funding to support its pipeline in rare neuromuscular and pulmonary diseases.

Downlod Santhera press release